Projects

Projects per year 1970 2024

• 23 Active
• 33 Finished

Projects per year

Search results

• Active

  IOFPOC42: IOF PoC “MOTIF: MOdification of T cells In situ for altered Functionality”

  Devoogdt, N., Breckpot, K., Meeus, F., De Groof, T. & De Vlaeminck, Y.

  1/01/21 → 31/12/22

  Project: Applied

• VOPPU95: VOPPU95 - Prijs kankeronderzoek - Wout De Mey

  Breckpot, K., Thielemans, K. & De Mey, W.

  1/01/21 → 30/06/21

  Project: Fundamental

• FWOAL1019: High intensity focused ultrasound and mRNA nanomedicines: a new strategy to induce and boost anti-tumor immunity

  Breckpot, K.

  1/01/21 → 31/12/24

  Project: Fundamental

• ani257: CARGO: advancing chimeric antigen receptor T cell therapy using nanobody-displaying lentiviral vectors

  Breckpot, K.

  1/11/20 → 31/10/21

  Project: Fundamental

• FWOSB101: CARGO: advancing chimeric antigen receptor T cell therapy using nanobody-displaying lentiviral vectors.

  Meeus, F. & Breckpot, K.

  1/11/20 → 31/10/22

  Project: Fundamental

• BRGRD44: Joint R&D 2020: "IMPACT: Invigorating precision Medicine by Predictive imaging of sdAb-based anti-Cancer Theranostics"

  Keyaerts, M., Krasniqi, A., Breckpot, K. & Goyvaerts, C.

  1/07/20 → 30/06/23

  Project: Applied

• OZR3588: Financiering FWO hercules: ERA platform: Extended RNA Analysis platform - version 2.0

  Rooman, I., Bouwens, L., Heimberg, H., Neyns, B., Vranken, W., Vanhaecke, T., Massie, A., van Grunsven, L., De Bruyne, E., De Bundel, D., Forsyth, R., Breckpot, K., Van Dooren, S., De Kock, J., Njemini, R. & Laoui, D.

  1/05/20 → 30/04/24

  Project: Fundamental

• IOF3009: GEAR: Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)

  Lahoutte, T., Devoogdt, N., Keyaerts, M., Van Ginderachter, J., Laoui, D., Raes, G., Breckpot, K. & Goyvaerts, C.

  1/01/20 → 31/12/24

  Project: Applied

• FWOSB80: Combining targeted radionuclide therapy and cancer immunotherapy to advance precision medicine through innovation.

  Breckpot, K., Devoogdt, N., D'Huyvetter, M., Keyaerts, M. & Ertveldt, T.

  1/11/19 → 31/10/21

  Project: Fundamental

• FWOSB81: Eccentric: Enhancing the function of Cancer Countering Effector cells using Nanobodies Targeting Regulatory Immune Checkpoints

  Breckpot, K., Devoogdt, N., Keyaerts, M. & Awad, R. M.

  1/11/19 → 31/10/21

  Project: Fundamental

• VLAHLT1: ICON project PERSOMED

  Breckpot, K. & Thielemans, K.

  1/10/19 → 30/09/21

  Project: Applied

• OZR3458: Research Council - Backup mandate Cleo Goyvaerts - Creation of a 3D CRiMe scene to unravel Cytotoxicity Resistant Mechanisms in non-small cell lung cancer.

  Goyvaerts, C. & Breckpot, K.

  1/10/19 → 30/09/21

  Project: Fundamental

• FWOSB58: Development of a NanoCAR-T cell approach for the treatment of multiple myeloma

  Hanssens, H., Devoogdt, N., De Veirman, K. & Breckpot, K.

  1/01/19 → 31/12/22

  Project: Fundamental

• FWOAL934: Smart design nanoParticles to Activate immune Responses against Cancer (SPARC)

  Breckpot, K., Keyaerts, M., Barbé, K. & De Smedt, S.

  1/01/19 → 31/12/22

  Project: Fundamental

• FWOSB59: Enhancing the immunogenicity and antitumor efficacy of virotherapy by supplementing an oncolytic virus with checkpoint inhibition and immunological cell death inducers

  Kalus, P., Aerts, J. & Breckpot, K.

  1/01/19 → 31/12/22

  Project: Fundamental

• FWOTM900: Modulating epigenetic mechanisms to enhance cancer immunotherapy.

  Breckpot, K., De Beck, L. & Maes, K.

  1/10/18 → 30/09/22

  Project: Fundamental

• HERC43: FWO Hercules MZW: Platform for cell analysis after radioactivity based Molecular Imaging and targeted Therapy of cancer (PeRMIT)

  Keyaerts, M., Breckpot, K., De Veirman, K. & Van Ginderachter, J.

  1/05/18 → 30/04/23

  Project: Fundamental

• FWOSBO21: SBO: MATATUM : Validation and druggability development of macrophage-specific targets in the tumor microenvironment

  Van Ginderachter, J., Breckpot, K., Lahoutte, T., Devoogdt, N. & Raes, G.

  1/01/18 → 31/12/21

  Project: Applied

• FWOSB43: Nanobody-mediated imaging and blocking of the inhibitory receptor LAG-3

  Lecocq, Q., Breckpot, K., Devoogdt, N. & Keyaerts, M.

  1/01/18 → 31/12/21

  Project: Fundamental

• SRP48: Strategic Research Programme: Cancer Cell Targeting in Myeloma and Melanoma (MyMe)

  Thielemans, K., Vanderkerken, K. & Breckpot, K.

  1/11/17 → 31/10/22

  Project: Fundamental

• AIIFUND14: Development of novel anti-checkpoint strategies based on nanobodies.

  Breckpot, K.

  1/10/17 → 14/05/21

  Project: Fundamental

• ANI184: Nanobody-targeted radionuclide therapy and immune therapy: a perfect match in the area of combination therapy.

  Breckpot, K. & Keyaerts, M.

  1/01/17 → 31/12/21

  Project: Fundamental

• ANI144: NICHE: Nanobody-mediated Immune CHEckpoint imaging and inhibition

  Breckpot, K., Thielemans, K. & Devoogdt, N.

  1/10/15 → 30/09/21

  Project: Fundamental